Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
about
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiologyAbiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utilityTherapy assessment in prostate cancer using choline and PSMA PET/CT.(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.
P2860
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Serial 18F-choline-PET imaging ...... ssment and imaging biomarkers.
@en
type
label
Serial 18F-choline-PET imaging ...... ssment and imaging biomarkers.
@en
prefLabel
Serial 18F-choline-PET imaging ...... ssment and imaging biomarkers.
@en
P2093
P2860
P50
P356
P1433
P1476
Serial 18F-choline-PET imaging ...... essment and imaging biomarkers
@en
P2093
Antonello Veccia
Davide Donner
Enzo Galligioni
Franca Chierichetti
Francesca Maines
Giampaolo Tortora
P2860
P304
P356
10.2217/FON.15.277
P407
P577
2016-01-15T00:00:00Z